Article

Leach, DA and Mohr, A and Giotis, ES and Cil, E and Isac, AM and Yates, LL and Barclay, WS and Zwacka, RM and Bevan, CL and Brooke, GN (2021) 'The antiandrogen enzalutamide downregulates TMPRSS2 and reduces cellular entry of SARS-CoV-2 in human lung cells.' Nature Communications, 12 (1). 4068-. ISSN 2041-1723

Mohr, A and Zwacka, RM (2018) 'The future of mesenchymal stem cell-based therapeutic approaches for cancer – From cells to ghosts.' Cancer Letters, 414. pp. 239-249. ISSN 0304-3835

Yu, R and Deedigan, L and Albarenque, SM and Mohr, A and Zwacka, RM (2013) 'Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects.' Cell Death & Disease, 4 (2). e503-e503. ISSN 2041-4889

Mohr, A and Büneker, C and Gough, RP and Zwacka, RM (2008) 'MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release.' Oncogene, 27 (6). pp. 763-774. ISSN 0950-9232

Mohr, A and Lyons, M and Mohr, W and Zwacka, RM (2007) 'Gentherapeutische Strategien gegen das kolorektale Karzinom [Gene therapy strategies for colorectal cancer].' Deutsche medizinische Wochenschrift (1946), 132 (11). pp. 567-570. ISSN 0012-0472

Mohr, A and Henderson, G and Dudus, L and Herr, I and Kuerschner, T and Debatin, K-M and Weiher, H and Fisher, KJ and Zwacka, RM (2004) 'AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression.' Gene Therapy, 11 (6). pp. 534-543. ISSN 0969-7128